Novonesis y SpeedAgro anuncian una alianza estratégica El acuerdo apunta a fortalecer la bioestimulación y la mitigación del estrés en los principales cultivos de Argentina. La entrada Novonesis y SpeedAgro anuncian una alianza estratégica pertenece a Todo Agro.

Bioestimulación y mitigación del estrés: una alianza para fortalecer los cultivos en Argentina Luego de más de una década de trabajo conjunto, Novonesis y SpeedAgro formalizaron un acuerdo que tuvo como primer resultado el desarrollo de SpeedGrow Intenzia, una formulación compleja y altamente concentrada que mejora los rendimientos.

Collage aus 3 Fotos und dem afb-Firmenlogo. Die 3 Fotos zeigen die Abholung und Einlagerung der Laptopspenden. Auf einer Rampe stehen 3 Paletten mit gespendeten Laptops. Labdoo-Helfer nehmen diese heraus und lagern sie in Faltboxen um.

Kurz vor Weihnachten schickte #afb social & green IT 3 weitere Paletten mit 350 Laptopspenden.
Diese Laptops wurden von afb #Compliance-konform gelöscht. Vielen Dank an afb und die 3 Spender Fa. Chr. Hansen GmbH / #Novonesis Group, #Ubritricity und #Staffbase. Vielen Dank
#labdoo

La coinoculación y el tratamiento profesional de semillas marcan la agenda técnica de la campaña La agricultura argentina consolida su transición hacia modelos de producción que integran eficiencia operativa con sostenibilidad biológica. En este proceso, dos conceptos emergen como claves de la campaña que finaliza: la coinoculación y la profesionalización del tratamiento de semillas. La entrada La coinoculación y el tratamiento profesional de semillas marcan la agenda técnica de la campaña pertenece a Todo Agro.

3 Fotos zeigen eine Abholung von IT-Spenden. Auf einer langen Rampe werden 2 Paletten mit einer elektrischen Ameise aus einem Lager gefahren. 3 Helfer von Labdoo öffnen die Kartons auf den Paletten und lagern die Laptopspenden in Faltboxen um. Anschließend werden die Faltboxen in Autos geladen und ins Labdoo-Lager gefahren.

Vielen Dank für insgesamt 150 Laptopspenden, die uns heute auf 2 Paletten erreicht haben. Je zur Hälfte kamen die #Laptops von #EURONICS aus #Ditzingen und Fa. #Novonesis.
Die Laptops werden in den kommenden Wochen zu Schulen und Projekten im In- und Ausland gehen
#labdoo #danke #spenden

2 Personen, je ein Mitarbeiter der Firmen novonesis und AfB gGmbH, stehen vor einem Bürogebäude, dahinter das Firmenlogo von Novonesis. Beide halten vor sich einen gespendeten Laptop.

Auf einer Straße steht ein Lkw mit heruntergefahrener Hebebühne. Auf dem Lkw sieht man den Schriftzug AfB. Ein AfB-Mitarbeiter steht zwischen Paletten, Gitterboxen und Transportboxen voller Laptop- und IT-Spenden.

Diese Woche spendete #Novonesis mehrere 100 Laptops für #Labdoo, vielen Dank.
Unser Partner #AfB gGmbH holte die große IT-Spende ab, wird die Laptops Compliance-konform löschen und die Laptops an Labdoo weiterleiten. Wir freuen uns schon auf diese große IT-Spende.
#nienburg #weser

Feed additive manufacturer dsm-firmenich’s Animal Nutrition & Health (ANH) business unit has opened a new feed additive plant at an existing facility near Hyderabad in India. #Buhler #DSMFirmenich #Novonesis
bit.ly/4nUno09

Logos of Novo Nordisk and Novonesis displayed over a blue-toned background of magnified gut microbiome imagery. Courtesy of Novonesis.

Novonesis and Novo Nordisk team up to explore how gut-targeted synbiotics might support metabolic health and tackle obesity and related conditions.

jcst2d.com/index.php/ne...

#Novonesis #NovoNordisk #GutMicrobiome #MetabolicHealth #ObesityPrevention

Nuevo inoculante de última generación: las bacterias alimentan al maní y engordan 6% sus rindes Novonesis presentó Nitragin® Fusion Pro, un inoculante de última generación especialmente desarrollado para el cultivo de maní, que ofrece una solución integral para maximizar el rendimiento y la eficiencia.

Revolutionizing Dairy Production: 21st.BIO's Alpha-Lactalbumin Program 21st.BIO has launched a new precision fermentation program for bovine alpha-lactalbumin, aimed at revolutionizing dairy production sustainably and efficiently.

Revolutionizing Dairy Production: 21st.BIO's Alpha-Lactalbumin Program #Denmark #Copenhagen #Novonesis #21st.BIO #alpha-lactalbumin

21st.BIO Introduces Revolutionary Precision Fermentation Program for Bovine Alpha-Lactalbumin 21st.BIO has launched a groundbreaking program for bovine alpha-lactalbumin through precision fermentation, making this vital protein more accessible and sustainable.

21st.BIO Introduces Revolutionary Precision Fermentation Program for Bovine Alpha-Lactalbumin #Denmark #Copenhagen #Novonesis #21st.BIO #alpha-lactalbumin

NSCEB Launches Biotech Roadshow to Strengthen U.S. Biotechnology Industry The NSCEB is embarking on a three-month roadshow to showcase the U.S. biotechnology ecosystem, starting in North Carolina. Key figures discuss advancements.

NSCEB Launches Biotech Roadshow to Strengthen U.S. Biotechnology Industry #United_States #Raleigh #biotech #NSCEB #Novonesis

UBS upgrades Novonesis to “buy,” cuts Kerry to “neutral” on growth outlook Investing.com -- UBS Global Research has upgraded Novonesis to “buy” from “neutral” and downgraded Kerry Group to “neutral” from “buy” in a shift of preferences within the global consumer chemicals and ingredients sector. The upgrade of Novonesis is underpinned by strong first-quarter results and improved confidence in the sustainability of its post-merger performance. UBS forecasts 8.3% organic sales growth for Novonesis in 2025, the highest among its coverage excluding AAK. Volume growth for the company is projected at 7.3%, also the highest across the sector. Novonesis’ EBITDA margin of 38.3% in Q1 FY25 and expected 36.1% for the full year 2024 significantly outpaces the peer average of 20.9%. These factors support a valuation rerating, with UBS raising its price target to DKK 530, representing an 18% increase from the prior estimate. UBS views the first-half 2025 results, due August 21, as a likely positive catalyst. The firm expects an organic sales growth beat for Q2 and anticipates upward revision to medium-term financial targets. UBS believes the shares still offer upside, with valuation metrics trading below long-term averages despite Novonesis’ superior growth and margin profile. Conversely, Kerry’s downgrade reflects limited short-term earnings momentum. Despite forecasting a solid 9% EPS CAGR for 2025–2028, UBS sees minimal potential for earnings upgrades over the next year. The company’s reliance on the U.S. market, where it derives about 39% of revenue, adds to caution amid fragile consumer confidence. Volume growth for 2025 is projected at 3.6%, broadly in line with consensus, and adjusted EPS is forecast at €5.01. Kerry currently trades at a 17.8x forward P/E, an 18% discount to its 10-year average and 19% below sector peers. UBS has raised its price target slightly to €107, citing foreign exchange benefits, but does not expect a rerating in the near term without a clear catalyst. DSM-Firmenich remains UBS’s top sector pick, with Novonesis now positioned as the second most preferred stock. Should you invest $1,000 in KYGa right now? Don't miss out on the next big opportunity! Stay ahead of the curve with ProPicks AI – 6 model portfolios powered by AI stock picks with a stellar performance in 2024. Unlock ProPicks to find out

Click Subscribe #StockMarket #Investing #FinancialNews #UBS #Novonesis

Original post on helpnetsecurity.com

Building cybersecurity culture in science-driven organizations In this Help Net Security intervie...

www.helpnetsecurity.com/2025/05/15/anne-sofie-ro...

#Don't #miss #Features #Hot […]

[Original post on helpnetsecurity.com]

Novonesis Aims to Elevate U.S. Biotech with National Security Insights Novonesis is set to drive U.S. biotech forward by implementing key recommendations from the National Security Commission's report on emerging biotechnology. Discover their strategies.

Novonesis Aims to Elevate U.S. Biotech with National Security Insights #None #biotechnology #National_Security #Novonesis

Multinational dsm-firmenich has divested its 50% share in a joint venture feed enzymes business to its partner Novonesis for €1.5 billion. #DSMFirmenich #Novonesis
bit.ly/4hZHYtv

Exciting prospects in bioenergy and functional foods, Novonesis CEO says Novonesis CEO Ester Baiget outlines the biotechnology company's key products and growth areas.

In a live interview with @cnbc.com from Davos, our CEO Ester Baiget shared the progress of Novonesis and our prospects going forward, outlining key growth areas.

Watch a 4-minute video clip of the interview here:
www.cnbc.com/video/2025/0...

#biosolutions #novonesis

Bluesky over #Novonesis, best place to work.
#firstpost

Happy to share a second paper from our collaboration with Chr Hansen (now #Novonesis) by Jensen et al in Physiologia Plantarum on how Bacillus subtilis promotes plant phosphorus acquisition through P solubilization and stimulation of root and root hair growth
dx.doi.org/10.1111/ppl....
#OA